Bank of New York Mellon Corp
BankPosition in DNLI — Denali Therapeutics Inc.
CIK 1390777
NEW YORK, NY
Position in DNLI
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$20,583,271
+$5,836,926 QoQ
Shares Held
800,283
+4.2% QoQ
Ownership
0.501%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#39
of 290 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 84%
Shared 0%
None 16%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $4,845,290,998 across 311 Biotechnology names. DNLI ranks #40 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,672,623 | $830,842,010 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
758,492 | $472,950,091 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,578,013 | $380,253,782 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
492,071 | $148,128,128 | |
| 5 | INSM |
INSMED Inc
|
1,312,756 | $139,966,036 | |
| 6 | MRNA |
Moderna, Inc.
|
1,701,675 | $119,168,293 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
601,056 | $112,565,759 | |
| 8 | INCY |
Incyte Corp
|
972,825 | $110,279,435 |
All Filings in DNLI
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,583,271 | 800,283 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $14,746,345 | 768,039 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $12,582,052 | 762,087 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $11,626,840 | 800,747 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $11,062,671 | 790,756 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $15,007,408 | 1,103,892 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $25,332,069 | 1,242,987 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $38,753,120 | 1,330,351 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $35,765,087 | 1,540,271 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $36,482,647 | 1,777,907 | Shares | Other | 2024-04-25 | |
| 2023-12-31 | $40,143,649 | 1,870,627 | Shares | Other | 2024-01-29 | |
| 2023-09-30 | $40,510,878 | 1,963,688 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $58,716,245 | 1,989,707 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $46,462,991 | 2,016,623 | Shares | Other | 2023-05-09 | |
| 2022-12-31 | $55,784,631 | 2,005,920 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $58,166,507 | 1,895,292 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $54,979,060 | 1,868,130 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $51,768,506 | 1,609,217 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $41,593,601 | 932,592 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $19,005,471 | 376,719 | Shares | Other | 2021-11-18 | |
| 2021-06-30 | $27,247,622 | 347,369 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $14,923,883 | 261,364 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $36,801,628 | 439,370 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $26,091,726 | 728,209 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $15,619,360 | 645,962 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $6,019,008 | 343,747 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||